Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ARTSS-2: A Pilot, Phase 2b, Randomized, Multi-center Trial of Argatroban in Combination With Recombinant Tissue Plasminogen Activator for Acute Stroke

NCT01464788 is registered in ClinicalTrials.gov with Andrew D. Barreto, MD as lead sponsor.

NCT NCT01464788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01464788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ARTSS-2: A Pilot, Phase 2b, Randomized, Multi-center Trial of Argatroban in Combination With Recombinant Tissue Plasminogen Activator for Acute Stroke
Lead sponsor
Andrew D. Barreto, MD
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2011
Completion date
June 11, 2015
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke